Aptatek Biosciences, Inc.
Aptatek Biosciences develops connected diagnostic tools for metabolic monitoring at home. Its investigational PheCheck programme measures blood phenylalanine for people with PKU.
UndisclosedInitial close of financing
LeadCS
Canterbury Scientific Ltd.
Activity from announced rounds
All recorded activity
- Rounds participated in
- 1
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share